JUN and posterior cortical atrophy: By co-integrating the tumor suppressor PTEN in our survival analysis, we found that levels of PTEN and JUN determine survival probabilities of PCa and revealed the worst prognosis in JUNlow/PTENlow PCa but highest RFS in JUNhigh/PTENhigh tumors.